Evidence map›Paper›PMID 35478125›Full record

ReviewIn vivo (Athens, Greece)

Timing and Duration of Axillary Lymph Node Swelling After COVID-19 Vaccination: Japanese Case Report and Literature Review.

Nobuyasu Yoshimoto, Akemi Yanagi, Satoru Takayama, Masaki Sakamoto, Keisuke Tomoda, Ken Ishikawa, Kohei Takura, Akifumi Kawate, Shoryu Takayama, Masakatsu Yamashita and 3 more

Open access · diamondAbstract readCase ReportsReview
PubMed Full text at PMC Publisher
In one paragraph

Review in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Nobuyasu YoshimotoDepartment of Breast Surgery, Nagoya Tokushukai General Hospital, Kasugai, Japan.
Akemi YanagiDepartment of Radiology, Nagoya Tokushukai General Hospital, Kasugai, Japan.
Satoru TakayamaDepartment of Surgery, Nagoya Tokushukai General Hospital, Kasugai, Japan.
Masaki SakamotoDepartment of Surgery, Nagoya Tokushukai General Hospital, Kasugai, Japan.
Keisuke TomodaDepartment of Surgery, Nagoya Tokushukai General Hospital, Kasugai, Japan.
Ken IshikawaDepartment of Surgery, Nagoya Tokushukai General Hospital, Kasugai, Japan.
Kohei TakuraDepartment of Surgery, Nagoya Tokushukai General Hospital, Kasugai, Japan.
Akifumi KawateDepartment of Surgery, Nagoya Tokushukai General Hospital, Kasugai, Japan.
Shoryu TakayamaDepartment of Surgery, Nagoya Tokushukai General Hospital, Kasugai, Japan.
Masakatsu YamashitaDepartment of Surgery, Nagoya Tokushukai General Hospital, Kasugai, Japan.
Shinya YamamotoDepartment of Surgery, Nagoya Tokushukai General Hospital, Kasugai, Japan.
Kioto YokoyamaDepartment of Surgery, Nagoya Tokushukai General Hospital, Kasugai, Japan.
Hisanori KaniDepartment of Surgery, Nagoya Tokushukai General Hospital, Kasugai, Japan.
Yao Tokushukai General Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimCOVID-19 vaccination is now performed in most of the world to limit the spread of the disease. The first mRNA vaccine was approved in clinical settings and has specific side effects including axillary lymph node swelling, which can be misdiagnosed as breast cancer metastasis. The timing of axillary lymph node swelling and its duration are unclear. Here, we present a Japanese case and review of the existing literature. CASE REPORT: We report the case of a 67-year-old woman with breast calcification. She had regular follow ups in our hospital for this calcification and received ultrasonography of the breast and axilla at every visit. She visited 6 months before having her COVID-19 vaccination, and 7 days and 6 months after the first COVID-19 vaccination. She had a swollen axillary lymph node 7 days after the first vaccination, which although it was improved, remained for 6 months.

conclusionAxillary lymph node swelling occurred 7 days after vaccination and remained up to 6 months after it.

Indexed as

Breast NeoplasmsCOVID-19Neoplasms, Second PrimaryAgedCOVID-19 VaccinesFemaleHumansJapanLymphatic MetastasisLymph NodesmRNA VaccinesVaccinationVaccines, SyntheticCOVID-19 VaccinesmRNA VaccinesVaccines, Syntheticaxillary lymph node swellingCOVID-19 vaccinetime-course change

Identifiers

PMID35478125
PMCPMC9087108
OpenAlexW4225083138

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.